United States · FDA National Drug Code directory

Fexofenadine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
73581-025_53e87c12-47d6-9a2f-e063-6294a90aaa6f
Product NDC
73581-025
Form
TABLET
Composition / generic term
Fexofenadine Hydrochloride
Labeler
YYBA Corp
Marketing category
ANDA
Marketing start / end (source format)
20251218
Source listing expiry
20271231

Source-listed ingredients

  • FEXOFENADINE HYDROCHLORIDE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET in 1 BOTTLE (73581-025-01) · 73581-025-01
  • 60 TABLET in 1 BOTTLE (73581-025-06) · 73581-025-06
  • 200 TABLET in 1 BOTTLE (73581-025-20) · 73581-025-20

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →